Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine

被引：0
|
作者：
Ralf Buettner
Le Xuan Truong Nguyen
Corey Morales
Min-Hsuan Chen
Xiwei Wu
Lisa S. Chen
Dinh Hoa Hoang
Servando Hernandez Vargas
Vinod Pullarkat
Varsha Gandhi
Guido Marcucci
Steven T. Rosen
机构：
[1] City of Hope Medical Center,Hematology Malignancies Research Institute, Gehr Family Center for Leukemia Research
[2] City of Hope Medical Center,Integrative Genomics Core, Beckman Research Institute
[3] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics
来源：
Journal of Hematology & Oncology | / 14卷
关键词：
Acute myeloid leukemia; Oxidative phosphorylation; Fatty acid oxidation; Nucleoside analog; Metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
    Chen, Xufeng
    Glytsou, Christina
    Zhou, Hua
    Narang, Sonali
    Reyna, Denis E.
    Lopez, Andrea
    Sakellaropoulos, Theodore
    Gong, Yixiao
    Kloetgen, Andreas
    Yap, Yoon Sing
    Wang, Eric
    Gavathiotis, Evripidis
    Tsirigos, Aristotelis
    Tibes, Raoul
    Aifantis, Iannis
    CANCER DISCOVERY, 2019, 9 (07) : 890 - 909
  • [22] Valproic Acid Enhances Venetoclax Efficacy in Targeting Acute Myeloid Leukemia
    Kawakatsu, Renshi
    Tadagaki, Kenjiro
    Yamasaki, Kenta
    Kuwahara, Yasumichi
    Yoshida, Tatsushi
    DISEASES, 2025, 13 (01)
  • [23] The combination of venetoclax and quercetin exerts a cytotoxic effect on acute myeloid leukemia
    Kawakatsu, Renshi
    Tadagaki, Kenjiro
    Yamasaki, Kenta
    Kuwahara, Yasumichi
    Nakada, Shinichiro
    Yoshida, Tatsushi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Venetoclax in combination with azacitidine or decitabine in relapsed/refractory acute myeloid leukemia
    Che, Yue
    Tan, Wanqing
    Liu, Ying
    Liu, Haitao
    Li, Lanlan
    Qin, Fangmei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) : 209 - 214
  • [25] VENETOCLAX IN COMBINATION AS A TREATMENT OF ACUTE MYELOID LEUKEMIA IN RECALLED OR REFRACTORY PATIENTS
    Hernandez Jasson, Villarreal
    Esteve Maria, Condom
    Marin Helena, Pomares
    Polo Susana, Vives
    Jorda Rosa, Coll
    Calvo Marta, Cervera
    Artigal Clara, Maluquer
    Fernandez Gladys, Ibarra
    Albert, Torrent
    Barajas Mercedes, Galiano
    Balari Anna, Sureda
    Sangerman Montserrat, Arnan
    HAEMATOLOGICA, 2021, 106 (10) : 215 - 215
  • [26] A novel approach to improve the pharmacokinetic properties of 8-chloro-adenosine by the dual combination of lipophilic derivatisation and liposome formulation
    Jiao, Yuan-yuan
    Wang, Xue-qing
    Lu, Wan-liang
    Yang, Zhen-jun
    Zhang, Qiang
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 48 (1-2) : 249 - 258
  • [27] Exploiting the Metabolic Vulnerability of Leukemic Stem Cells (LSCs) in Inv(16) Acute Myeloid Leukemia (AML) with the Combination of Miristen, a Mir-126 Inhibitor, and Venetoclax
    Zhang, Lianjun
    Dinh Hoa Hoang
    Kang, Hyunjun
    Chen, Ying-Chieh
    Fu, Yu-Hsuan
    Pathak, Khyatiben V.
    Valerio, Melissa
    Chen, Fang
    Estrella, Katrina
    Buettner, Ralf
    Zhang, Bin
    Pirrotte, Patrick
    Marcucci, Guido
    Kuo, Ya-Huei
    Le Xuan Truong Nguyen
    BLOOD, 2023, 142
  • [28] Targeting Venetoclax Resistance in TP53-Mutated Acute Myeloid Leukemia
    Vanttinen, Ida
    Ruokoranta, Tanja
    Saad, Joseph J.
    Kytola, Sari
    Hellesoy, Monica
    Gullaksen, Stein-Erik
    Ettala, Pia-Sofia
    Pyorala, Marja
    Rimpilainen, Johanna
    Siitonen, Timo
    Wennerberg, Krister
    Gjertsen, Bjorn T.
    Heckman, Caroline A.
    Kontro, Mika
    Kuusanmaki, Heikki
    BLOOD, 2023, 142
  • [29] The ribonucleoside analog, 8-chloro-adenosine, induces autophagy in primary chronic lymphocytic leukemia cells in vitro and in vivo
    Stellrecht, Christine M.
    Balakrishnan, Kumudha
    Dennison, Jennifer B.
    Shentu, Shujun
    Ayres, Mary
    Wierda, William G.
    Gandhi, Varsha
    CANCER RESEARCH, 2011, 71
  • [30] Dihydroorotate Dehydrogenase: An Unexpected Metabolic Vulnerability in Acute Myeloid Leukemia
    Sykes, David B.
    ONCOLOGIST, 2016, 21 : S3 - S3
12345